top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
Ariel Victorio
ASGCT 2024: A Look at Participating Organizations
The American Society of Gene and Cell Therapy (ASGCT) is currently in full swing, bringing together the brightest minds in gene and cell...
Feb 1, 2024
Research Focus Areas for CAR-T
By definition, CAR-T cell therapy modifies a patient's T cells in order to target cancer cells, using a special receptor called a...
Feb 1, 2024
Key Amgen Pipeline Readouts in 2024
The biotechnology giant presented an impressive range of new drugs, highlighting advancements in different therapeutic areas signaling a...
Jan 30, 2024
JPM 2024 Corporate Development/M&A Highlights
We reviewed the JP Morgan 2024 Healthcare conference presentations from the largest pharma/biopharma companies to understand their 2024...
Jan 26, 2024
Lesser-known U.S. Cell Therapy Companies with Phase 3 or Approved Asset
We searched our online BiopharmIQ platform, for cell therapy companies that have a Phase 3 or later (including approved) asset. We found...
Jan 17, 2024
Cell & Gene Tx Startups by State
The Southeastern region of the U.S. is an exciting area where biotechnology has been growing over the past few decades. With respect to...
Jan 17, 2024
Ovarian Cancer Market And Treatments
A recent corporate slide deck from Zentalis^1 provides helpful information regarding the current high unmet needs in treating ovarian...
Dec 9, 2023
A Day to Celebrate Biotech - First Gene Editing Approval
Yesterday was a day to celebrate biotech! 🥳 Congrats to Vertex and CRISPR Therapeutics on FDA approval of CASGEVY • 1st product that...
Nov 21, 2023
3 Key Insights From FDA’s 1st Review of Gene Editing
BACKGROUND 1st Gene Editing AdCom On 10/31/23 an FDA AdCom met to discuss the safety of VRTX/CRSP’s exa-cel (CTX001) to reduce or...
Aug 15, 2023
Pieris Restructuring Provides a Variety of Opportunities
Category: Job Candidates & Partnering opportunities Opportunity: Job candidates - R&D, IP assets (Biopharma corp dev), Corp public...
Aug 15, 2023
Importance of Clinical Trial Data Analysis Highlighted by NKTR/LLY Dispute
Category: Clinical Trial News Opportunity: Marketing material for clinical trial data analysis CROs and vendors Issue: Incorrect clinical...
Aug 9, 2023
Experienced Cardio Sales & Other Professions Coming Available from Amarin Layoffs
Category: Employee recruiting Opportunity: US and European sales reps are coming available from AMRN layoffs Company: Amarin Corporation...
Aug 2, 2023
AAV vector safety - FDA Insight (May ‘23)
Category: FDA & gene therapy safety Opportunity: Proactively address FDA issues re: AAV vector safety Trigger event: May 2023 FDA AdComm...
Jul 31, 2023
Biopharma Acquisition: Biogen Acquiring Reata Pharmaceuticals
Category: Acquisition Company: Reata Pharmaceuticals Product/Asset: SKYCLARYS Issue: Acquisition Latest trigger event for Opp: PR July...
Jul 21, 2023
Viridian Initiating Ph1 and Ph2/3 Trials Starting This Quarter & Needs SQ Delivery Partner
Category: Trial Initiations & biotech partnerships Opportunity: Trial initiations & drug delivery device/Sub-Q partner(s) Company:...
Jul 21, 2023
SCPH SQ FUROSCIX Commercial Launch Provides Opportunities for Recruiters & Insurance Consultant
Category: Insurance coverage and sales force size/biotech recruiting Opportunity: Hiring/staffing & headhunters, Health care insurance &...
Jul 19, 2023
Galera Lawsuit Against IQVIA / Alira Health Underscores Importance of Clinical Data Analysis Partner
Category: Lawsuit Opportunity: Data analysis companies can use this incident to help convince potential customers of the importance of...
Jul 19, 2023
Recent Novartis Acquisition Highlights Need for Better Tech for Drug Targeting Outside Liver
Category: M&A Opportunity: Need for better tech to delivery drugs outside liver & value to big pharma Company: Novartis & DTx Pharma...
Jul 18, 2023
July 2023: BlueBird Bio Clinical Trial Safety Insight
Category: Gene Therapy Safety Opportunity: Improved lentiviral gene therapy drug development and genetic testing Company: BlueBird Bio...
Jul 17, 2023
Prothena Corporation & Bristol Myers Squibb Collaboration
Prothena Corporation technology validated by big Bristol Myers Squibb collaboration • Bristol Myers is part owner of Prothena Bristol...
Jul 14, 2023
Biopharma Bite Sized News - July 10th to 14th 2023
Cell therapy data, cancer trial safety-induced hold, potential mergers, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...
bottom of page